PubRank

W B Forman

Author PubWeight™ 26.38‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate. Final report of VA Cooperative Study #75. Cancer 1984 1.32
2 An inherited qualitative abnormality in plasma fibrinogen: fibrinogen Cleveland. J Lab Clin Med 1968 0.99
3 Enzymatic conversion of salicylate to salicylurate. Mol Pharmacol 1971 0.99
4 Effect of warfarin on survival in small cell carcinoma of the lung. Veterans Administration Study No. 75. JAMA 1981 0.97
5 Studies on the nature of antihemophilic factor (factor VIII). Further evidence relating the AHF-like antigens in normal and hemophilic plasmas. J Clin Invest 1973 0.94
6 Abnormalities of blood coagulation tests in patients with cancer. Am J Clin Pathol 1987 0.92
7 Treatment of haemophilia (factor-8 deficiency) with human antihaemophilic factor prepared by the cryoprecipitate process. Lancet 1967 0.92
8 Consolidation and maintenance therapy in multiple myeloma: randomized comparison of a new approach to therapy after initial response to treatment. J Clin Oncol 1986 0.91
9 Criteria for the differentiation of dysfibrinogenemic states. Semin Hematol 1976 0.90
10 Accrual of patients into a multihospital cancer clinical trial and its implications on planning future studies. Am J Clin Oncol 1984 0.89
11 Rationale and experimental design for the VA Cooperative Study of Anticoagulation (Warfarin) in the Treatment of Cancer. Cancer 1979 0.89
12 Diffuse pulmonary infection due to Strongyloides stercoralis. JAMA 1974 0.87
13 Nonsynthetizing multiple myeloma. Haematologia (Budap) 1977 0.85
14 Fibrin formation: effect of calcium ions. Blood 1978 0.83
15 Transdermal fentanyl disposition in elderly subjects. Gerontology 1994 0.82
16 Tumor conference: the role of continuing medical education. J Contin Educ Health Prof 1988 0.82
17 Periorbital ecchymoses as the initial sign in multiple myeloma. Ann Ophthalmol 1982 0.82
18 Two primary carcinomas of the lung: adenocarcinoma and a metachronous squamous cell carcinoma. A case report and review of the literature. Cancer 1983 0.81
19 Academy of hospice physicians' position statement on access to hospice and palliative care. J Pain Symptom Manage 1996 0.81
20 Fibrin formation: the role of the fibrinogen-fibrin monomer complex. Thromb Haemost 1976 0.79
21 Life expectancy, comorbidity, and quality of life. A framework of reference for medical decisions. Clin Geriatr Med 1997 0.79
22 Transurethral resection in a patient with a dysfibrinogen: fibrinogen cleveland I. J Urol 1977 0.78
23 Esophageal carcinoma. A six-year review of the Cleveland Veterans Administration Hospital experience. Cancer 1984 0.78
24 Bleeding complications from warfarin anticoagulation in patients with malignancy. J Med 1985 0.78
25 Cancer in persons with inherited blood coagulation disorders. Cancer 1979 0.77
26 Comparison of high-performance liquid chromatography and a spectrophotometric technique for determining plasma warfarin. J Chromatogr 1978 0.77
27 Formal geriatric assessment, An imperative for the older person with cancer. Cancer Pract 1997 0.77
28 Pain management for the geriatric patient. Clin Podiatr Med Surg 1994 0.76
29 Effect of mopidamol on survival in carcinoma of the lung and colon: final report of Veterans Administration Cooperative Study No. 188. J Natl Cancer Inst 1988 0.76
30 On the 10th anniversary of the organization of the American Academy of Hospice and Palliative Medicine (AAHPM): the first 10 years. Am J Hosp Palliat Care 2001 0.76
31 A simplified method for monitoring heparin therapy at the bedside: the activated whole blood clotting time. Am J Hematol 1981 0.75
32 Rapid and sensitive method for the determination of salicylic acid in serum by reversed-phase ion-pair high-performance liquid chromatography. J Chromatogr 1983 0.75
33 Metoclopramide-induced hypertensive crisis. Clin Pharm 1984 0.75
34 Techniques for demonstration of the specificity of circulating anticoagulants against antihemophilic factor (factor VIII), with studies of two cases possibly related to diphenylhydantoin therapy. Blood 1977 0.75
35 Comparison of local versus central tumor measurements in a multicenter cancer trial. Am J Clin Oncol 1984 0.75
36 Cytarabine-induced anaphylaxis. Demonstration of antibody and successful desensitization. Arch Intern Med 1980 0.75
37 Phase II evaluation of chlorozotocin in refractory multiple myeloma. Cancer Treat Rep 1984 0.75
38 A simplified method for isolation of the S-carboxymethyl derivative chains of normal fibrinogen and fibrinogen Cleveland and I. Thromb Res 1976 0.75
39 Platelets and malignancy. Rationale and experimental design for the VA Cooperative Study of RA-233 in the treatment of cancer. Am J Clin Oncol 1982 0.75
40 Granulocytopenia with marked lymphocytosis manifesting Sjogren syndrome. Am J Hematol 1980 0.75
41 Symptomatic management of the older person with cancer. Clin Geriatr Med 1997 0.75